Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Dimerix Limited ( (AU:DXB) ) has issued an announcement.
Dimerix Limited has announced the application for the quotation of 6,961 fully paid ordinary securities on the Australian Securities Exchange (ASX). This move, following the exercise of options or conversion of convertible securities, reflects the company’s ongoing efforts to strengthen its market position and enhance shareholder value.
More about Dimerix Limited
Dimerix Limited operates in the biotechnology industry, focusing on developing innovative therapies for unmet medical needs.
YTD Price Performance: 35.29%
Average Trading Volume: 2,348,417
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: A$256.8M
See more data about DXB stock on TipRanks’ Stock Analysis page.
